These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
Delaware
|
|
91-2066376
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification Number)
|
|
5408 NE 88th Street, Building E
Vancouver, Washington 98665
|
||
|
(Address of principal executive office, including zip code)
|
||
|
(360) 566-4460
|
||
|
|
(Registrant’s telephone number, including area code)
__________________________________________
|
|
|
Title of Each Class
|
Trading Symbol
|
Name of Exchange on which Registered
|
|
Common Stock, par value
$0.0001 per share
|
LASR
|
The Nasdaq Stock Market LLC
|
|
Large Accelerated Filer
|
o
|
Accelerated Filer
|
o
|
Non-Accelerated Filer
|
x
|
Smaller Reporting Company
|
o
|
|
|
|
|
|
|
|
Emerging Growth Company
|
x
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
Page
|
|
|
|
|
|
September 30,
|
|
December 31,
|
||||
|
|
2019
|
|
2018
|
||||
|
Assets
|
|
|
|
||||
|
Current assets:
|
|
|
|
||||
|
Cash and cash equivalents
|
$
|
138,863
|
|
|
$
|
149,478
|
|
|
Accounts receivable, net of allowances of $340 and $303
|
28,757
|
|
|
26,528
|
|
||
|
Inventory
|
45,719
|
|
|
35,329
|
|
||
|
Prepaid expenses and other current assets
|
4,713
|
|
|
7,286
|
|
||
|
Total current assets
|
218,052
|
|
|
218,621
|
|
||
|
Property and equipment, net of accumulated depreciation of $57,116 and $53,812
|
25,784
|
|
|
21,462
|
|
||
|
Intangible assets, net of accumulated amortization of $2,615 and $2,049
|
3,113
|
|
|
2,686
|
|
||
|
Goodwill
|
1,387
|
|
|
1,387
|
|
||
|
Other assets
|
7,132
|
|
|
5,974
|
|
||
|
Total assets
|
$
|
255,468
|
|
|
$
|
250,130
|
|
|
|
|
|
|
||||
|
Liabilities and Stockholders’ Equity
|
|
|
|
||||
|
Current liabilities:
|
|
|
|
||||
|
Accounts payable
|
$
|
15,460
|
|
|
$
|
12,068
|
|
|
Accrued liabilities
|
9,778
|
|
|
10,708
|
|
||
|
Deferred revenues
|
454
|
|
|
720
|
|
||
|
Current portion of long-term debt
|
66
|
|
|
91
|
|
||
|
Total current liabilities
|
25,758
|
|
|
23,587
|
|
||
|
Non-current income taxes payable
|
6,809
|
|
|
6,472
|
|
||
|
Long-term debt
|
—
|
|
|
18
|
|
||
|
Other long-term liabilities
|
1,681
|
|
|
2,270
|
|
||
|
Total liabilities
|
34,248
|
|
|
32,347
|
|
||
|
Stockholders' equity:
|
|
|
|
||||
|
Preferred stock - $0.0001 par value; 5,000 shares authorized, zero shares issued and outstanding at September 30, 2019 and December 31, 2018.
|
—
|
|
|
—
|
|
||
|
Common stock - $0.0001 par value; 190,000 shares authorized, 37,744 shares issued and outstanding at September 30, 2019 and 190,000 shares authorized, 36,705 shares issued and outstanding at December 31, 2018.
|
15
|
|
|
15
|
|
||
|
Additional paid-in capital
|
331,169
|
|
|
324,656
|
|
||
|
Accumulated other comprehensive loss
|
(3,226
|
)
|
|
(2,157
|
)
|
||
|
Accumulated deficit
|
(106,738
|
)
|
|
(104,731
|
)
|
||
|
Total stockholders’ equity
|
221,220
|
|
|
217,783
|
|
||
|
Total liabilities and stockholders’ equity
|
$
|
255,468
|
|
|
$
|
250,130
|
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
|
Revenues
|
$
|
43,814
|
|
|
$
|
51,025
|
|
|
$
|
133,723
|
|
|
$
|
145,197
|
|
|
Cost of revenues
|
30,852
|
|
|
32,978
|
|
|
91,376
|
|
|
94,742
|
|
||||
|
Gross profit
|
12,962
|
|
|
18,047
|
|
|
42,347
|
|
|
50,455
|
|
||||
|
Operating expenses:
|
|
|
|
|
|
|
|
||||||||
|
Research and development
|
6,402
|
|
|
5,475
|
|
|
19,318
|
|
|
14,656
|
|
||||
|
Sales, general, and administrative
|
7,256
|
|
|
7,485
|
|
|
23,972
|
|
|
20,955
|
|
||||
|
Total operating expenses
|
13,658
|
|
|
12,960
|
|
|
43,290
|
|
|
35,611
|
|
||||
|
Income (loss) from operations
|
(696
|
)
|
|
5,087
|
|
|
(943
|
)
|
|
14,844
|
|
||||
|
Other income (expense):
|
|
|
|
|
|
|
|
||||||||
|
Interest income, net
|
665
|
|
|
298
|
|
|
2,155
|
|
|
73
|
|
||||
|
Other income (expense), net
|
90
|
|
|
(537
|
)
|
|
3
|
|
|
(503
|
)
|
||||
|
Income before income taxes
|
59
|
|
|
4,848
|
|
|
1,215
|
|
|
14,414
|
|
||||
|
Income tax expense
|
837
|
|
|
839
|
|
|
3,383
|
|
|
2,836
|
|
||||
|
Net income (loss)
|
$
|
(778
|
)
|
|
$
|
4,009
|
|
|
$
|
(2,168
|
)
|
|
$
|
11,578
|
|
|
Less: Income allocated to participating securities
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(4,415
|
)
|
|
Net income (loss) attributable to common stockholders
|
$
|
(778
|
)
|
|
$
|
4,009
|
|
|
$
|
(2,168
|
)
|
|
$
|
7,163
|
|
|
Net income (loss) per share, basic
|
$
|
(0.02
|
)
|
|
$
|
0.11
|
|
|
$
|
(0.06
|
)
|
|
$
|
0.34
|
|
|
Net income (loss) per share, diluted
|
$
|
(0.02
|
)
|
|
$
|
0.10
|
|
|
$
|
(0.06
|
)
|
|
$
|
0.27
|
|
|
Shares used in per share calculations:
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
37,262
|
|
|
35,007
|
|
|
37,005
|
|
|
20,946
|
|
||||
|
Diluted
|
37,262
|
|
|
40,332
|
|
|
37,005
|
|
|
26,138
|
|
||||
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
|
Net income (loss)
|
$
|
(778
|
)
|
|
$
|
4,009
|
|
|
$
|
(2,168
|
)
|
|
$
|
11,578
|
|
|
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
||||||||
|
Foreign currency translation adjustments, net of tax
|
(1,126
|
)
|
|
(625
|
)
|
|
(1,069
|
)
|
|
(1,263
|
)
|
||||
|
Comprehensive income (loss)
|
$
|
(1,904
|
)
|
|
$
|
3,384
|
|
|
$
|
(3,237
|
)
|
|
$
|
10,315
|
|
|
|
Three Months Ended September 30, 2019
|
||||||||||||||||||||||||||||
|
|
Preferred stock
|
|
Common stock
|
|
Additional paid-in capital
|
|
Accumulated other comprehensive income (loss)
|
|
Accumulated deficit
|
|
Total stockholders' equity
|
||||||||||||||||||
|
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
|
|
|
|
||||||||||||||||||
|
Balance, June 30, 2019
|
—
|
|
|
$
|
—
|
|
|
37,665
|
|
|
$
|
15
|
|
|
$
|
329,982
|
|
|
$
|
(2,100
|
)
|
|
$
|
(105,960
|
)
|
|
$
|
221,937
|
|
|
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(778
|
)
|
|
(778
|
)
|
||||||
|
Issuance of common stock pursuant to exercise of stock options
|
—
|
|
|
—
|
|
|
77
|
|
|
—
|
|
|
117
|
|
|
—
|
|
|
—
|
|
|
117
|
|
||||||
|
Issuance of common stock pursuant to vesting of restricted stock awards and units, net of stock withheld for tax
|
—
|
|
|
—
|
|
|
2
|
|
|
—
|
|
|
(9
|
)
|
|
—
|
|
|
—
|
|
|
(9
|
)
|
||||||
|
Stock-based compensation
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,079
|
|
|
—
|
|
|
—
|
|
|
1,079
|
|
||||||
|
Cumulative translation adjustment
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,126
|
)
|
|
—
|
|
|
(1,126
|
)
|
||||||
|
Balance, September 30, 2019
|
—
|
|
|
$
|
—
|
|
|
37,744
|
|
|
$
|
15
|
|
|
$
|
331,169
|
|
|
$
|
(3,226
|
)
|
|
$
|
(106,738
|
)
|
|
$
|
221,220
|
|
|
|
Nine Months Ended September 30, 2019
|
||||||||||||||||||||||||||||
|
|
Preferred stock
|
|
Common stock
|
|
Additional paid-in capital
|
|
Accumulated other comprehensive income (loss)
|
|
Accumulated deficit
|
|
Total stockholders' equity
|
||||||||||||||||||
|
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
|
|
||||||||||||||||||||
|
Balance, December 31, 2018
|
—
|
|
|
$
|
—
|
|
|
36,705
|
|
|
$
|
15
|
|
|
$
|
324,656
|
|
|
$
|
(2,157
|
)
|
|
$
|
(104,731
|
)
|
|
$
|
217,783
|
|
|
Cumulative effect adjustment due to adoption of ASU 2018-07
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(161
|
)
|
|
—
|
|
|
161
|
|
|
—
|
|
||||||
|
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,168
|
)
|
|
(2,168
|
)
|
||||||
|
Issuance of common stock pursuant to exercise of stock options
|
—
|
|
|
—
|
|
|
595
|
|
|
—
|
|
|
1,032
|
|
|
—
|
|
|
—
|
|
|
1,032
|
|
||||||
|
Issuance of common stock pursuant to vesting of restricted stock awards and units, net of stock withheld for tax
|
—
|
|
|
—
|
|
|
401
|
|
|
—
|
|
|
(489
|
)
|
|
—
|
|
|
—
|
|
|
(489
|
)
|
||||||
|
Issuance of common stock under the Employee Stock Purchase Plan
|
—
|
|
|
—
|
|
|
43
|
|
|
—
|
|
|
762
|
|
|
—
|
|
|
—
|
|
|
762
|
|
||||||
|
Stock-based compensation
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5,369
|
|
|
—
|
|
|
—
|
|
|
5,369
|
|
||||||
|
Cumulative translation adjustment
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,069
|
)
|
|
—
|
|
|
(1,069
|
)
|
||||||
|
Balance, September 30, 2019
|
—
|
|
|
$
|
—
|
|
|
37,744
|
|
|
$
|
15
|
|
|
$
|
331,169
|
|
|
$
|
(3,226
|
)
|
|
$
|
(106,738
|
)
|
|
$
|
221,220
|
|
|
|
Three Months Ended September 30, 2018
|
||||||||||||||||||||||||||||
|
|
Convertible preferred stock
|
|
Common stock
|
|
Additional paid-in capital
|
|
Accumulated other comprehensive income (loss)
|
|
Accumulated deficit
|
|
Total stockholders' equity
|
||||||||||||||||||
|
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
|
|
|
|
||||||||||||||||||
|
Balance, June 30, 2018
|
—
|
|
|
$
|
—
|
|
|
34,792
|
|
|
$
|
15
|
|
|
$
|
282,678
|
|
|
$
|
(1,357
|
)
|
|
$
|
(111,100
|
)
|
|
$
|
170,236
|
|
|
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4,009
|
|
|
4,009
|
|
||||||
|
Proceeds from follow-on offering
|
—
|
|
|
—
|
|
|
1,520
|
|
|
—
|
|
|
40,286
|
|
|
—
|
|
|
—
|
|
|
40,286
|
|
||||||
|
Exercise of stock options
|
—
|
|
|
—
|
|
|
44
|
|
|
—
|
|
|
38
|
|
|
—
|
|
|
—
|
|
|
38
|
|
||||||
|
Stock-based compensation
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,903
|
|
|
—
|
|
|
—
|
|
|
1,903
|
|
||||||
|
Deferred offering costs
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,427
|
)
|
|
—
|
|
|
—
|
|
|
(2,427
|
)
|
||||||
|
Cumulative translation adjustment
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(625
|
)
|
|
—
|
|
|
(625
|
)
|
||||||
|
Balance, September 30, 2018
|
—
|
|
|
$
|
—
|
|
|
36,356
|
|
|
$
|
15
|
|
|
$
|
322,478
|
|
|
$
|
(1,982
|
)
|
|
$
|
(107,091
|
)
|
|
$
|
213,420
|
|
|
|
Nine Months Ended September 30, 2018
|
||||||||||||||||||||||||||||
|
|
Convertible preferred stock
|
|
Common stock
|
|
Additional paid-in capital
|
|
Accumulated other comprehensive loss
|
|
Accumulated deficit
|
|
Total stockholders' equity
|
||||||||||||||||||
|
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
|
|
|
|
||||||||||||||||||
|
Balance, December 31, 2017
|
24,642
|
|
|
$
|
12
|
|
|
2,979
|
|
|
$
|
2
|
|
|
$
|
180,657
|
|
|
$
|
(719
|
)
|
|
$
|
(118,669
|
)
|
|
$
|
61,283
|
|
|
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
11,578
|
|
|
11,578
|
|
||||||
|
Proceeds from public offerings
|
—
|
|
|
—
|
|
|
8,420
|
|
|
1
|
|
|
150,685
|
|
|
—
|
|
|
—
|
|
|
150,686
|
|
||||||
|
Conversion of convertible preferred stock to common stock
|
(24,642
|
)
|
|
(12
|
)
|
|
24,642
|
|
|
12
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Exercise of warrants for common stock
|
—
|
|
|
—
|
|
|
15
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Exercise of stock options
|
—
|
|
|
—
|
|
|
300
|
|
|
—
|
|
|
161
|
|
|
—
|
|
|
—
|
|
|
161
|
|
||||||
|
Stock-based compensation
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,871
|
|
|
—
|
|
|
—
|
|
|
2,871
|
|
||||||
|
Deferred offering costs
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(11,896
|
)
|
|
—
|
|
|
—
|
|
|
(11,896
|
)
|
||||||
|
Cumulative translation adjustment
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,263
|
)
|
|
—
|
|
|
(1,263
|
)
|
||||||
|
Balance, September 30, 2018
|
—
|
|
|
$
|
—
|
|
|
36,356
|
|
|
$
|
15
|
|
|
$
|
322,478
|
|
|
$
|
(1,982
|
)
|
|
$
|
(107,091
|
)
|
|
$
|
213,420
|
|
|
|
Nine Months Ended September 30,
|
||||||
|
|
2019
|
|
2018
|
||||
|
Cash flows from operating activities:
|
|
|
|
||||
|
Net income (loss)
|
$
|
(2,168
|
)
|
|
$
|
11,578
|
|
|
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
|
|
|
|
||||
|
Depreciation
|
4,859
|
|
|
4,415
|
|
||
|
Amortization
|
1,935
|
|
|
1,897
|
|
||
|
Provision for losses on (recoveries of) accounts receivable
|
58
|
|
|
(34
|
)
|
||
|
Stock-based compensation
|
5,369
|
|
|
2,871
|
|
||
|
Loss (gain) on disposal of property and equipment
|
(7
|
)
|
|
11
|
|
||
|
Loss on debt extinguishment
|
—
|
|
|
12
|
|
||
|
Changes in operating assets and liabilities:
|
|
|
|
||||
|
Accounts receivable, net
|
(2,836
|
)
|
|
(8,382
|
)
|
||
|
Inventory
|
(11,055
|
)
|
|
(7,071
|
)
|
||
|
Prepaid expenses and other current assets
|
2,590
|
|
|
(3,076
|
)
|
||
|
Other assets
|
(2,670
|
)
|
|
(1,405
|
)
|
||
|
Accounts payable
|
3,290
|
|
|
1,517
|
|
||
|
Accrued and other long-term liabilities
|
(1,337
|
)
|
|
(702
|
)
|
||
|
Deferred revenues
|
(259
|
)
|
|
(291
|
)
|
||
|
Non-current income taxes payable
|
337
|
|
|
802
|
|
||
|
Net cash provided by (used in) operating activities
|
(1,894
|
)
|
|
2,142
|
|
||
|
Cash flows from investing activities:
|
|
|
|
||||
|
Purchases of property, equipment and patents
|
(10,007
|
)
|
|
(8,654
|
)
|
||
|
Proceeds from sale of property and equipment
|
19
|
|
|
8
|
|
||
|
Net cash used in investing activities
|
(9,988
|
)
|
|
(8,646
|
)
|
||
|
Cash flows from financing activities:
|
|
|
|
||||
|
Principal payments on debt and capital leases
|
(67
|
)
|
|
(17,300
|
)
|
||
|
Net proceeds from debt financing
|
—
|
|
|
16,053
|
|
||
|
Proceeds from public offerings, net of offering costs
|
—
|
|
|
139,089
|
|
||
|
Proceeds from employee stock plan purchases
|
762
|
|
|
—
|
|
||
|
Proceeds from stock option exercises
|
1,032
|
|
|
161
|
|
||
|
Tax payments related to stock award issuances
|
(489
|
)
|
|
—
|
|
||
|
Net cash provided by financing activities
|
1,238
|
|
|
138,003
|
|
||
|
Effect of exchange rate changes on cash
|
29
|
|
|
(4
|
)
|
||
|
Net increase (decrease) in cash and cash equivalents
|
(10,615
|
)
|
|
131,495
|
|
||
|
Cash and cash equivalents, beginning of period
|
149,478
|
|
|
36,687
|
|
||
|
Cash and cash equivalents, end of period
|
$
|
138,863
|
|
|
$
|
168,182
|
|
|
Supplemental disclosures:
|
|
|
|
||||
|
Cash paid (received) for interest
|
$
|
(2,265
|
)
|
|
$
|
802
|
|
|
Cash paid for income taxes
|
1,741
|
|
|
2,703
|
|
||
|
Accrued purchases of property, equipment and patents
|
1,275
|
|
|
709
|
|
||
|
Accrued deferred offering costs
|
—
|
|
|
830
|
|
||
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||
|
|
2019
|
|
2018
|
|
2019
|
|
2018
|
|
Quick Laser Technology Co., Ltd.
|
12%
|
|
12%
|
|
10%
|
|
14%
|
|
Raytheon Company
|
15%
|
|
*
|
|
12%
|
|
*
|
|
|
September 30, 2019
|
|||||||||||
|
|
Level 1
|
Level 2
|
Level 3
|
Total
|
||||||||
|
Money market securities
|
$
|
120,148
|
|
$
|
—
|
|
$
|
—
|
|
$
|
120,148
|
|
|
Commercial paper
|
2,325
|
|
—
|
|
—
|
|
2,325
|
|
||||
|
Total
|
$
|
122,473
|
|
$
|
—
|
|
$
|
—
|
|
$
|
122,473
|
|
|
|
December 31, 2018
|
|||||||||||
|
|
Level 1
|
Level 2
|
Level 3
|
Total
|
||||||||
|
Money market securities
|
$
|
123,121
|
|
$
|
—
|
|
$
|
—
|
|
$
|
123,121
|
|
|
Commercial paper
|
299
|
|
—
|
|
—
|
|
299
|
|
||||
|
Total
|
$
|
123,420
|
|
$
|
—
|
|
$
|
—
|
|
$
|
123,420
|
|
|
|
September 30, 2019
|
|
December 31, 2018
|
||||
|
Raw materials
|
$
|
16,714
|
|
|
$
|
14,174
|
|
|
Work in process and semi-finished goods
|
18,635
|
|
|
12,807
|
|
||
|
Finished goods
|
10,370
|
|
|
8,348
|
|
||
|
|
$
|
45,719
|
|
|
$
|
35,329
|
|
|
|
September 30, 2019
|
|
December 31, 2018
|
||||
|
Demonstration assets, net
|
$
|
2,241
|
|
|
$
|
1,982
|
|
|
Deferred tax assets, net
|
3,114
|
|
|
3,114
|
|
||
|
Other
|
1,777
|
|
|
878
|
|
||
|
|
$
|
7,132
|
|
|
$
|
5,974
|
|
|
|
September 30, 2019
|
|
December 31, 2018
|
||||
|
Accrued payroll and benefits
|
$
|
5,931
|
|
|
$
|
6,474
|
|
|
Product warranty, current
|
1,725
|
|
|
2,669
|
|
||
|
Income tax payable
|
492
|
|
|
258
|
|
||
|
Other accrued expenses
|
1,630
|
|
|
1,307
|
|
||
|
|
$
|
9,778
|
|
|
$
|
10,708
|
|
|
|
Nine Months Ended September 30,
|
||||||
|
|
2019
|
|
2018
|
||||
|
Product warranty liability, beginning
|
$
|
4,555
|
|
|
$
|
4,186
|
|
|
Warranty charges incurred, net
|
(1,971
|
)
|
|
(2,412
|
)
|
||
|
Provision for warranty charges, net of adjustments
|
456
|
|
|
3,569
|
|
||
|
Product warranty liability, ending
|
$
|
3,040
|
|
|
$
|
5,343
|
|
|
Less: current portion of product warranty liability
|
(1,725
|
)
|
|
(3,614
|
)
|
||
|
Non-current portion of product warranty liability
|
$
|
1,315
|
|
|
$
|
1,729
|
|
|
|
|
|
Number of Restricted Stock Awards
|
|
Weighted-Average Grant Date Fair Value
|
|||
|
RSAs at December 31, 2018
|
|
115
|
|
|
$
|
37.15
|
|
|
|
|
Awards granted
|
|
340
|
|
|
15.60
|
|
|
|
|
Awards vested
|
|
(11
|
)
|
|
37.15
|
|
|
|
RSAs at September 30, 2019
|
|
444
|
|
|
$
|
20.65
|
|
|
|
|
|
|
Number of Restricted Stock Units
|
|
Weighted-Average Grant Date Fair Value
|
|||
|
RSUs at December 31, 2018
|
|
557
|
|
|
$
|
30.31
|
|
|
|
|
Awards granted
|
|
1,019
|
|
|
18.51
|
|
|
|
|
Awards vested
|
|
(88
|
)
|
|
33.38
|
|
|
|
|
Awards forfeited
|
|
(20
|
)
|
|
29.74
|
|
|
|
RSUs at September 30, 2019
|
|
1,468
|
|
|
$
|
21.94
|
|
|
|
|
Number of Options
|
|
Weighted Average Exercise Price
|
|
Weighted Average Remaining Contractual Term (Years)
|
|
Aggregate Intrinsic Value
|
|
|
Outstanding, December 31, 2018
|
5,171
|
|
|
$1.60
|
|
7.2
|
|
$83,700
|
|
Options exercised
|
(595
|
)
|
|
$1.74
|
|
|
|
|
|
Options canceled
|
(47
|
)
|
|
$2.95
|
|
|
|
|
|
Outstanding, September 30, 2019
|
4,529
|
|
|
$1.56
|
|
6.4
|
|
$63,844
|
|
Options exercisable at September 30, 2019
|
3,112
|
|
|
$1.04
|
|
6.0
|
|
$45,501
|
|
Options vested as of September 30, 2019 and expected to vest after September 30, 2019
|
4,529
|
|
|
$1.56
|
|
6.4
|
|
$63,844
|
|
|
Nine Months Ended
|
||
|
|
September 30, 2019
|
||
|
Shares issued
|
43
|
|
|
|
Weighted average per share purchase price
|
$
|
17.91
|
|
|
Weighted average per share discount from the fair value of our common stock on date of issuance
|
$
|
3.16
|
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
|
Cost of revenues
|
$
|
340
|
|
|
$
|
183
|
|
|
$
|
816
|
|
|
$
|
267
|
|
|
Research and development
|
424
|
|
|
513
|
|
|
1,693
|
|
|
738
|
|
||||
|
Sales, general and administrative
|
315
|
|
|
1,207
|
|
|
2,860
|
|
|
1,866
|
|
||||
|
|
$
|
1,079
|
|
|
$
|
1,903
|
|
|
$
|
5,369
|
|
|
$
|
2,871
|
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
|
Numerator:
|
|
|
|
|
|
|
|
||||||||
|
Net income (loss)
|
$
|
(778
|
)
|
|
$
|
4,009
|
|
|
$
|
(2,168
|
)
|
|
$
|
11,578
|
|
|
Participating securities:
|
|
|
|
|
|
|
|
||||||||
|
Income allocated to participating securities
|
—
|
|
|
—
|
|
|
—
|
|
|
(4,415
|
)
|
||||
|
Net income (loss) attributable to common stockholders
|
(778
|
)
|
|
4,009
|
|
|
(2,168
|
)
|
|
7,163
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Denominator:
|
|
|
|
|
|
|
|
||||||||
|
Weighted-average shares, basic
|
37,262
|
|
|
35,007
|
|
|
37,005
|
|
|
20,946
|
|
||||
|
Dilutive effect of warrants
|
—
|
|
|
162
|
|
|
—
|
|
|
150
|
|
||||
|
Dilutive effect of restricted stock units and awards
|
—
|
|
|
15
|
|
|
—
|
|
|
7
|
|
||||
|
Dilutive effect of common stock options
|
—
|
|
|
5,148
|
|
|
—
|
|
|
5,035
|
|
||||
|
Weighted-average common shares outstanding, diluted
|
37,262
|
|
|
40,332
|
|
|
37,005
|
|
|
26,138
|
|
||||
|
Net income (loss) per share attributable to common stockholders:
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
$
|
(0.02
|
)
|
|
$
|
0.11
|
|
|
$
|
(0.06
|
)
|
|
$
|
0.34
|
|
|
Diluted
|
$
|
(0.02
|
)
|
|
$
|
0.10
|
|
|
$
|
(0.06
|
)
|
|
$
|
0.27
|
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||
|
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||
|
Restricted stock units and awards
|
1,912
|
|
|
541
|
|
|
1,912
|
|
|
541
|
|
|
Employee stock purchase plan
|
33
|
|
|
—
|
|
|
77
|
|
|
—
|
|
|
Common stock options
|
4,529
|
|
|
—
|
|
|
4,529
|
|
|
—
|
|
|
Total
|
6,474
|
|
|
541
|
|
|
6,518
|
|
|
541
|
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||
|
|
2019
|
|
2019
|
||||
|
Industrial
|
$
|
18,977
|
|
|
$
|
58,021
|
|
|
Microfabrication
|
13,280
|
|
|
45,907
|
|
||
|
Aerospace and Defense
|
11,557
|
|
|
29,795
|
|
||
|
|
$
|
43,814
|
|
|
$
|
133,723
|
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||
|
|
2019
|
|
2019
|
||||
|
North America
|
$
|
16,382
|
|
|
$
|
50,294
|
|
|
China
|
17,397
|
|
|
49,251
|
|
||
|
Rest of World
|
10,035
|
|
|
34,178
|
|
||
|
|
$
|
43,814
|
|
|
$
|
133,723
|
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||
|
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||
|
Revenues
|
100.0
|
%
|
|
100.0
|
%
|
|
100.0
|
%
|
|
100.0
|
%
|
|
Cost of revenues
|
70.4
|
|
|
64.6
|
|
|
68.3
|
|
|
65.3
|
|
|
Gross profit
|
29.6
|
|
|
35.4
|
|
|
31.7
|
|
|
34.7
|
|
|
Operating expenses:
|
|
|
|
|
|
|
|
||||
|
Research and development
|
14.6
|
|
|
10.7
|
|
|
14.5
|
|
|
10.1
|
|
|
Sales, general, and administrative
|
16.6
|
|
|
14.7
|
|
|
17.9
|
|
|
14.4
|
|
|
Total operating expenses
|
31.2
|
|
|
25.4
|
|
|
32.4
|
|
|
24.5
|
|
|
Income (loss) from operations
|
(1.6
|
)
|
|
10.0
|
|
|
(0.7
|
)
|
|
10.2
|
|
|
Other income (expense):
|
|
|
|
|
|
|
|
||||
|
Interest income, net
|
1.5
|
|
|
0.6
|
|
|
1.6
|
|
|
0.1
|
|
|
Other income (expense), net
|
0.2
|
|
|
(1.1
|
)
|
|
—
|
|
|
(0.3
|
)
|
|
Income before income taxes
|
0.1
|
|
|
9.5
|
|
|
0.9
|
|
|
10.0
|
|
|
Income tax expense
|
1.9
|
|
|
1.6
|
|
|
2.5
|
|
|
2.0
|
|
|
Net income (loss)
|
(1.8
|
)%
|
|
7.9
|
%
|
|
(1.6
|
)%
|
|
8.0
|
%
|
|
|
Three Months Ended September 30,
|
|
Change
|
|||||||||||||||
|
|
2019
|
% of Revenue
|
|
2018
|
% of Revenue
|
|
$
|
|
%
|
|||||||||
|
Industrial
|
$
|
18,977
|
|
43.3
|
%
|
|
$
|
20,890
|
|
41.0
|
%
|
|
$
|
(1,913
|
)
|
|
(9.2
|
)%
|
|
Microfabrication
|
13,280
|
|
30.3
|
|
|
19,922
|
|
39.0
|
|
|
(6,642
|
)
|
|
(33.3
|
)
|
|||
|
Aerospace and Defense
|
11,557
|
|
26.4
|
|
|
10,213
|
|
20.0
|
|
|
1,344
|
|
|
13.2
|
|
|||
|
|
$
|
43,814
|
|
100.0
|
%
|
|
$
|
51,025
|
|
100.0
|
%
|
|
$
|
(7,211
|
)
|
|
(14.1
|
)%
|
|
|
Nine Months Ended September 30,
|
|
Change
|
|||||||||||||||
|
|
2019
|
% of Revenue
|
|
2018
|
% of Revenue
|
|
$
|
|
%
|
|||||||||
|
Industrial
|
$
|
58,021
|
|
43.4
|
%
|
|
$
|
65,287
|
|
45.0
|
%
|
|
$
|
(7,266
|
)
|
|
(11.1
|
)%
|
|
Microfabrication
|
45,907
|
|
34.3
|
|
|
55,037
|
|
37.9
|
|
|
(9,130
|
)
|
|
(16.6
|
)
|
|||
|
Aerospace and Defense
|
29,795
|
|
22.3
|
|
|
24,873
|
|
17.1
|
|
|
4,922
|
|
|
19.8
|
|
|||
|
|
$
|
133,723
|
|
100.0
|
%
|
|
$
|
145,197
|
|
100.0
|
%
|
|
$
|
(11,474
|
)
|
|
(7.9
|
)%
|
|
|
Three Months Ended September 30,
|
|
Change
|
|||||||||||||||
|
|
2019
|
% of Revenue
|
|
2018
|
% of Revenue
|
|
$
|
|
%
|
|||||||||
|
North America
|
$
|
16,382
|
|
37.4
|
%
|
|
$
|
20,097
|
|
39.4
|
%
|
|
$
|
(3,715
|
)
|
|
(18.5
|
)%
|
|
China
|
17,397
|
|
39.7
|
|
|
16,683
|
|
32.7
|
|
|
714
|
|
|
4.3
|
|
|||
|
Rest of World
|
10,035
|
|
22.9
|
|
|
14,245
|
|
27.9
|
|
|
(4,210
|
)
|
|
(29.6
|
)
|
|||
|
|
$
|
43,814
|
|
100.0
|
%
|
|
$
|
51,025
|
|
100.0
|
%
|
|
$
|
(7,211
|
)
|
|
(14.1
|
)%
|
|
|
Nine Months Ended September 30,
|
|
Change
|
|||||||||||||||
|
|
2019
|
% of Revenue
|
|
2018
|
% of Revenue
|
|
$
|
|
%
|
|||||||||
|
North America
|
$
|
50,294
|
|
37.6
|
%
|
|
$
|
52,648
|
|
36.3
|
%
|
|
$
|
(2,354
|
)
|
|
(4.5
|
)%
|
|
China
|
49,251
|
|
36.8
|
|
|
55,476
|
|
38.2
|
|
|
(6,225
|
)
|
|
(11.2
|
)
|
|||
|
Rest of World
|
34,178
|
|
25.6
|
|
|
37,073
|
|
25.5
|
|
|
(2,895
|
)
|
|
(7.8
|
)
|
|||
|
|
$
|
133,723
|
|
100.0
|
%
|
|
$
|
145,197
|
|
100.0
|
%
|
|
$
|
(11,474
|
)
|
|
(7.9
|
)%
|
|
|
Three Months Ended
September 30, |
|
Change
|
|||||||||||
|
|
2019
|
|
2018
|
|
$
|
|
%
|
|||||||
|
Cost of revenues
|
$
|
30,852
|
|
|
$
|
32,978
|
|
|
$
|
(2,126
|
)
|
|
(6.4
|
)%
|
|
Gross profit
|
12,962
|
|
|
18,047
|
|
|
(5,085
|
)
|
|
(28.2
|
)
|
|||
|
Gross margin
|
29.6
|
%
|
|
35.4
|
%
|
|
—
|
|
|
(5.8
|
)%
|
|||
|
|
Nine Months Ended
September 30, |
|
Change
|
|||||||||||
|
|
2019
|
|
2018
|
|
$
|
|
%
|
|||||||
|
Cost of revenues
|
$
|
91,376
|
|
|
$
|
94,742
|
|
|
$
|
(3,366
|
)
|
|
(3.6
|
)%
|
|
Gross profit
|
42,347
|
|
|
50,455
|
|
|
(8,108
|
)
|
|
(16.1
|
)
|
|||
|
Gross margin
|
31.7
|
%
|
|
34.7
|
%
|
|
—
|
|
|
(3.0
|
)%
|
|||
|
|
Three Months Ended
September 30, |
|
Change
|
|||||||||||
|
|
2019
|
|
2018
|
|
$
|
|
%
|
|||||||
|
Research and development
|
$
|
6,402
|
|
|
$
|
5,475
|
|
|
$
|
927
|
|
|
16.9
|
%
|
|
|
Nine Months Ended
September 30, |
|
Change
|
|||||||||||
|
|
2019
|
|
2018
|
|
$
|
|
%
|
|||||||
|
Research and development
|
$
|
19,318
|
|
|
$
|
14,656
|
|
|
$
|
4,662
|
|
|
31.8
|
%
|
|
|
Three Months Ended
September 30, |
|
Change
|
|||||||||||
|
|
2019
|
|
2018
|
|
$
|
|
%
|
|||||||
|
Sales, general, and administrative
|
$
|
7,256
|
|
|
$
|
7,485
|
|
|
$
|
(229
|
)
|
|
(3.1
|
)%
|
|
|
Nine Months Ended
September 30, |
|
Change
|
|||||||||||
|
|
2019
|
|
2018
|
|
$
|
|
%
|
|||||||
|
Sales, general, and administrative
|
$
|
23,972
|
|
|
$
|
20,955
|
|
|
$
|
3,017
|
|
|
14.4
|
%
|
|
|
Three Months Ended
September 30, |
|
Change
|
||||||||||
|
|
2019
|
|
2018
|
|
$
|
|
%
|
||||||
|
Interest income, net
|
$
|
665
|
|
|
$
|
298
|
|
|
$
|
367
|
|
|
123.2%
|
|
|
Nine Months Ended
September 30, |
|
Change
|
||||||||||
|
|
2019
|
|
2018
|
|
$
|
|
%
|
||||||
|
Interest income, net
|
$
|
2,155
|
|
|
$
|
73
|
|
|
$
|
2,082
|
|
|
NM
|
|
|
Three Months Ended
September 30, |
|
Change
|
||||||||||
|
|
2019
|
|
2018
|
|
$
|
|
%
|
||||||
|
Other income (expense), net
|
$
|
90
|
|
|
$
|
(537
|
)
|
|
$
|
627
|
|
|
NM
|
|
|
Nine Months Ended
September 30, |
|
Change
|
||||||||||
|
|
2019
|
|
2018
|
|
$
|
|
%
|
||||||
|
Other income (expense), net
|
$
|
3
|
|
|
$
|
(503
|
)
|
|
$
|
506
|
|
|
NM
|
|
|
Three Months Ended
September 30, |
|
Change
|
|||||||||||
|
|
2019
|
|
2018
|
|
$
|
|
%
|
|||||||
|
Income tax expense
|
$
|
837
|
|
|
$
|
839
|
|
|
$
|
(2
|
)
|
|
(0.2
|
)%
|
|
|
Nine Months Ended
September 30, |
|
Change
|
|||||||||||
|
|
2019
|
|
2018
|
|
$
|
|
%
|
|||||||
|
Income tax expense
|
$
|
3,383
|
|
|
$
|
2,836
|
|
|
$
|
547
|
|
|
19.3
|
%
|
|
|
Nine Months Ended September 30,
|
||||||
|
|
2019
|
|
2018
|
||||
|
Net cash provided by (used in) operating activities
|
$
|
(1,894
|
)
|
|
$
|
2,142
|
|
|
Net cash used in investing activities
|
(9,988
|
)
|
|
(8,646
|
)
|
||
|
Net cash provided by financing activities
|
1,238
|
|
|
138,003
|
|
||
|
Effect of exchange rate changes on cash
|
29
|
|
|
(4
|
)
|
||
|
Net increase (decrease) in cash
|
$
|
(10,615
|
)
|
|
$
|
131,495
|
|
|
|
|
|
|
|
|
|
|
|
|
|
•
|
cease the manufacture, use or sale of the infringing products, processes or technology;
|
|
•
|
pay substantial damages for infringement;
|
|
•
|
expend significant resources to develop non-infringing products, processes or technology;
|
|
•
|
license technology from the party claiming infringement, which license may not be available on commercially reasonable terms, or at all;
|
|
•
|
cross-license our technology to a competitor to resolve an infringement claim, which could weaken our ability to compete with that competitor; or
|
|
•
|
pay substantial damages to our direct or indirect customers to cause our end users to discontinue their use of, or replace, infringing products with non-infringing products.
|
|
•
|
the increase, decrease, cancellation or rescheduling of significant customer orders;
|
|
•
|
declines in selling prices for our products;
|
|
•
|
delays in our product-shipment timing, obtaining licenses or other import/export approvals, customer or end-user sales or deployment cycles, or work performed under development contracts;
|
|
•
|
seasonality attributable to different purchasing patterns and levels of activity throughout the year in the areas where we operate;
|
|
•
|
the timing of revenue recognition based on the installation or acceptance of certain products shipped to our customers;
|
|
•
|
timing variability in product introductions, enhancements, services and technologies by us and our competitors and market acceptance of these new or enhanced products, services and technologies;
|
|
•
|
our ability to obtain export licenses for our products on a timely basis or at all;
|
|
•
|
changes in tariffs imposed by the U.S., China and other foreign governments;
|
|
•
|
the rate at which our present and future customers and end users adopt our technologies;
|
|
•
|
the gain or loss of a key customer;
|
|
•
|
product or customer mix;
|
|
•
|
competitive pricing pressures and new market entrants;
|
|
•
|
our ability to design, manufacture and introduce new products on a cost-effective and timely basis;
|
|
•
|
our ability to manage our inventory levels and any write-downs for excess or obsolete inventory;
|
|
•
|
our ability to collect outstanding accounts receivable balances;
|
|
•
|
changes in the amount and timing of our operating costs, including those related to the expansion of our business, operations and infrastructure;
|
|
•
|
impairment of values for goodwill, intangibles and other long-lived assets;
|
|
•
|
different capital expenditure and budget cycles for our customers, which affect the timing of their spending;
|
|
•
|
foreign currency fluctuations;
|
|
•
|
changes in jurisdictional income mix and tax rules and regulations in countries where we operate; and
|
|
•
|
economic and market conditions in a particular geography or country.
|
|
•
|
changing product specifications and customer requirements;
|
|
•
|
unanticipated engineering complexities;
|
|
•
|
expense reduction measures we have implemented, and others we may implement, to conserve our cash and attempt to sustain profitability;
|
|
•
|
difficulties in hiring and retaining necessary technical personnel;
|
|
•
|
difficulties in reallocating engineering resources and overcoming resource limitations; and
|
|
•
|
changing market or competitive product requirements.
|
|
•
|
merge or consolidate;
|
|
•
|
sell or transfer assets outside the ordinary course of business;
|
|
•
|
make certain types of investments and capital expenditures;
|
|
•
|
incur additional indebtedness or guarantee indebtedness of others;
|
|
•
|
pay dividends, redeem or repurchase our capital stock;
|
|
•
|
enter into transactions with affiliates outside the ordinary course of business; and
|
|
•
|
create liens on our assets.
|
|
•
|
price and volume fluctuations in the overall stock market from time to time;
|
|
•
|
changes in operating performance, stock market valuations and volatility in the market prices of other technology companies generally, or those in our industry in particular;
|
|
•
|
actual or anticipated quarterly variations in our results of operations or those of our competitors;
|
|
•
|
actual or anticipated changes in our growth rate relative to our competitors;
|
|
•
|
announcements by us or our competitors of acquisitions, new products, significant contracts, commercial relationships or capital commitments;
|
|
•
|
manufacturing or supply interruptions;
|
|
•
|
developments with respect to intellectual property rights;
|
|
•
|
our ability to develop and market new and enhanced products on a timely basis;
|
|
•
|
commencement of, or our involvement in, litigation;
|
|
•
|
major changes in our Board of Directors or management;
|
|
•
|
changes in governmental regulations or in the status of our regulatory approvals;
|
|
•
|
the trading volume of our stock;
|
|
•
|
any future sales of our common stock or other securities;
|
|
•
|
failure of financial analysts to maintain coverage of us, changes in financial estimates by any analysts who follow our company or our failure to meet these estimates or the expectations of investors;
|
|
•
|
fluctuations in the values of companies perceived by investors to be comparable to us;
|
|
•
|
the financial projections we may provide to the public, any changes in these projections or our failure to meet these projections; and
|
|
•
|
general economic conditions and slow or negative growth of related markets.
|
|
•
|
permit the Board of Directors to issue up to 5 million shares of preferred stock, with any rights, preferences and privileges as they may designate;
|
|
•
|
provide that the authorized number of directors may be changed only by resolution of the Board of Directors;
|
|
•
|
provide that all vacancies on our Board of Directors may only be filled by our Board of Directors and not by stockholders;
|
|
•
|
divide the Board of Directors into three classes;
|
|
•
|
provide that a director may only be removed from the Board of Directors by the stockholders for cause;
|
|
•
|
require that any action to be taken by our stockholders must be effected at a duly called annual or special meeting of stockholders and may not be taken by written consent;
|
|
•
|
provide that stockholders seeking to present proposals before a meeting of stockholders or to nominate candidates for election as directors at a meeting of stockholders must provide notice in writing in a timely manner and meet specific requirements as to the form and content of a stockholder's notice;
|
|
•
|
prevent cumulative voting rights (therefore allowing the holders of a plurality of the shares of common stock entitled to vote in any election of directors to elect all of the directors standing for election, if they should so choose);
|
|
•
|
provide that special meetings of our stockholders may be called only by the chairman of the board, our chief executive officer (or president, in the absence of a chief executive officer) or by the Board of Directors; and
|
|
•
|
provide that stockholders will be permitted to amend our amended and restated certificate of incorporation and amended and restated bylaws only upon receiving at least two-thirds of the total votes entitled to be cast by holders of all outstanding shares then entitled to vote generally in the election of directors, voting together as a single class.
|
|
Exhibit
Number
|
|
Incorporated by Reference
|
Filed
Herewith
|
|||
|
Description
|
Form
|
File No.
|
Exhibit
|
Filing Date
|
||
|
3.1
|
10-Q
|
001-38462
|
3.1
|
May 25, 2018
|
|
|
|
3.2
|
10-Q
|
001-38462
|
3.2
|
May 25, 2018
|
|
|
|
4.1
|
S-1/A
|
333-224055
|
4.1
|
April 16, 2018
|
|
|
|
4.2
|
S-1
|
333-224055
|
4.2
|
March 30, 2018
|
|
|
|
31.1
|
|
|
|
|
X
|
|
|
31.2
|
|
|
|
|
X
|
|
|
32.1*
|
|
|
|
|
X
|
|
|
101.INS
|
XBRL Instance Document.
|
|
|
|
|
X
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
X
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document.
|
|
|
|
|
X
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
X
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
X
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
X
|
|
*
|
The certifications furnished in Exhibit 32.1 hereto are deemed to accompany this Quarterly Report on Form 10-Q and will not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, except to the extent that the registrant specifically incorporates it by reference.
|
|
|
|
NLIGHT, INC.
|
|
|
|
(Registrant)
|
|
|
|
|
|
|
|
|
|
November 6, 2019
|
By:
|
/s/ SCOTT KEENEY
|
|
Date
|
|
Scott Keeney
|
|
|
|
President and Chief Executive Officer
(Principal Executive Officer) |
|
|
|
|
|
November 6, 2019
|
By:
|
/s/ RAN BAREKET
|
|
Date
|
|
Ran Bareket
|
|
|
|
Chief Financial Officer
(Principal Accounting and Financial Officer) |
|
|
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|